Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amoy Dx
AddedJul 2, 2026
UpdatedJul 2, 2026
Amoy Dx

Amoy Dx

Public

Amoy Dx is a leading provider of molecular diagnostic solutions for precision oncology and companion diagnostics.

HQ
Xiamen, Fujian, CN
Founded
2008
Overview
Compare
Fundraising
Employees
News
Website

Amoy Diagnostics Co., Ltd., founded in 2008 in Xiamen, Fujian, China, develops and commercializes PCR and NGS-based IVD kits and companion diagnostics for oncology, including the Pan Lung Cancer PCR Panel and HANDLE NGS panels with technologies like Super-ARMS and HRD scoring. Its products have gained approvals from NMPA, MHLW, CE and others and support targeted therapies for patients in over 60 countries.

The company listed on SZSE (300685) in 2017 and maintains partnerships with global pharma for CDx development. It is a Qiming Venture Partners portfolio company focused on precision medicine diagnostics.

Amoy Dx - Similar Companies

LynxDx logo

LynxDx

lynxdx.com

Co-Diagnostics logo

Co-Diagnostics

co-dx.com

AgenDx Biosciences logo

AgenDx Biosciences

Amydis logo

Amydis

amydis.com

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

Plasmonic Diagnostics logo

Plasmonic Diagnostics

CareDx logo

CareDx

caredx.com

ADM Diagnostics logo

ADM Diagnostics

admdx.com

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

Precipio logo

Precipio

precipiodx.com

DxNA logo

DxNA

AOA Dx logo

AOA Dx

aoadx.com

AxonDx logo

AxonDx

axondx.com

MultiplexDX logo

MultiplexDX

multiplexdx.com

Molecular Detection logo

Molecular Detection

Amoy Dx - Quick Facts

Who are Amoy Dx's competitors?

Companies similar to Amoy Dx include LynxDx, Co-Diagnostics, AgenDx Biosciences and Amydis.

When was Amoy Dx founded?

Amoy Dx was founded in 2008.

Where is Amoy Dx's headquarters located?

Amoy Dx's headquarters is located in Xiamen, Fujian, CN.

How much has Amoy Dx raised to-date?

As of Aug 2, 2017, Amoy Dx has raised a total of $50M (USD).

Amoy Dx - Classification

Industry
  • Biotechnology
Tags
  • Molecular Diagnostics